- Home
- CTRM vs KTTA Comparison
CTRM vs KTTA Comparison
Compare CTRM & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRM | KTTA |
|---|---|---|
| Founded | 2016 | 2020 |
| Country | Cyprus | United States |
| Employees | N/A | 4 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 18.9M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTRM | KTTA |
|---|---|---|
| Price | $2.08 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 43.0K | ★ 641.4K |
| Earning Date | 04-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.66 | $0.28 |
| 52 Week High | $2.65 | $2.06 |
Technical Indicators
Market Signals| Indicator | CTRM | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 63.45 | 37.42 |
| Support Level | $2.01 | $0.54 |
| Resistance Level | $2.20 | $0.78 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 82.68 | 4.50 |
Price Performance
Historical ComparisonAbout CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).